Buy Checkpoint Therapeutics Stock | CKPT Stock Price & Latest News | Public.com

CKPT

Checkpoint Therapeutics

$0.00 (0.00%)Today

About CKPT

Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio include CK-301, CK-101, CK-103, and CK-302....Read more

Community

People who own or watch this stock

Buy any stock with any amount of money.

Download the App
Download the app

What Wall Street Thinks

Rating

What Wall St. analysts suggest for this stock

1

Price Targets

What analysts think this stock will be worth

$1.84
current
$15.67
average

Earnings

The value each share was expected to gain vs. the value that each share actually gained

0
-0.07
-0.15
-0.22
Q4 2019
Q1 2020
Q2 2020
Q3 2020

Expected EPS
Q3 2020

-$0.10

Actual EPS
Q3 2020

Stats

Market Cap$105,71M
Volume24,57k
Price-to-Earnings Ratio
Dividend Rate
Dividend Yield
1 Year High$3.34
1 Year Low$1.05
Open$1.93
High$1.93
Low$1.69

Buy any stock with any amount of money.

Download the App
Download the app